Next |
home / stock / cerc / cerc message board
Subject | By | Source | When |
---|---|---|---|
New board is: https://investorshub.advfn.com/Avalo-Therapeutics-AVTX-40053/ | AliasUser1 | investorshub | 09/14/2021 10:00:46 PM |
$cerc Cerecor wins Fast Track Designation https://www.biospace.com/article/2021- | frankkruemmel | investorshub | 05/11/2021 4:41:12 PM |
And up 25% this morning | JohnLocke101 | investorshub | 05/11/2021 1:43:22 PM |
Biggest negative operating margin ever seen -706.02%, book | make it happen | investorshub | 05/11/2021 1:28:10 PM |
https://www.marketwatch.com/story/cerecors-investigational-covid-19-therapy-gets | frankkruemmel | investorshub | 05/11/2021 1:13:09 PM |
https://finance.yahoo.com/news/cerecor-announces-worldwide-license-agreemen | JohnLocke101 | investorshub | 03/29/2021 11:21:08 AM |
Oppenheimer Weighs in on Cerecor Inc.s FY2025 Earnings (NASDAQ:$CERC) | JohnLocke101 | investorshub | 03/12/2021 8:00:17 PM |
Hanging strong in a volatile Daq market. | JohnLocke101 | investorshub | 03/12/2021 4:20:12 PM |
Nice move in the overall market rally. Needs | JohnLocke101 | investorshub | 03/09/2021 4:30:22 PM |
Just a heads up that $CERC filed a | JohnLocke101 | investorshub | 03/09/2021 12:34:39 PM |
Same | CYDYWinning | investorshub | 03/09/2021 3:51:04 AM |
Added at 3.04 on the dip. | JohnLocke101 | investorshub | 03/08/2021 7:09:27 PM |
Starter position on this dip under $3 | JohnLocke101 | investorshub | 03/05/2021 3:54:55 PM |
Lets gooooo | Billydakidd | investorshub | 02/03/2021 2:24:10 AM |
$2.60 in | Dubster watching | investorshub | 01/08/2021 8:24:18 PM |
Bought a lot of shares. Ready for a | Stockyang | investorshub | 08/30/2020 3:49:10 AM |
Interesting | swingingRichard | investorshub | 08/05/2020 2:58:44 AM |
COVID related update. Fundamentals are Excellent ... https://finance.yahoo.com/news/cerecor-announce | PennyWorld | investorshub | 07/21/2020 5:29:38 PM |
MASSIVE Insider Buying over past week !! | PennyWorld | investorshub | 06/15/2020 10:19:57 PM |
News out today read here: Cerecor and | Jcbaby1 | investorshub | 05/26/2020 11:55:35 AM |
News, Short Squeeze, Breakout and More Instantly...
Topline results from planned Phase 2 trial of AVTX-009 in hidradenitis suppurativa expected in 2026 Cash on hand of approximately $110 million as of March 31, 2024 with expected cash runway into 2027 WAYNE, Pa. and ROCKVILLE, Md., May 13, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeut...
Appointments include industry veterans Aaron Kantoff, Jonathan Goldman, and Samantha Truex as Independent Directors Board of Director appointments in conjunction with Avalo’s recent acquisition of AVTX-009, an anti-IL-1β mAb, and up to $185 million private placement financ...
Acquired AVTX-009, Phase-2 ready anti-IL-1β mAb, in March 2024 Increased cash position with private placement financing in March 2024 providing up to $185 million, including initial upfront investment of $115.6 million Topline results from planned Phase 2 trial of AVTX-00...